Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Acute Migraine
Age Range:
18 to 75
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This research study is evaluating an investigational medication called Elismetrep (K-304) for the acute treatment of migraine. Researchers are studying the safety and effectiveness of Elismetrep in adults who experience migraine with or without aura.
Qualifications
You may be able to join if you:
Are 18 to 75 years of age
Have a history of migraine with or without aura for at least one year
Experience migraine attacks on a recurring basis
Are willing to use an electronic diary on your own smartphone device during the study
Are willing to treat one qualifying migraine attack with study medication
FEATURED STUDIES
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase […]
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]